Skip to main content
. Author manuscript; available in PMC: 2016 Sep 23.
Published in final edited form as: Oncogene. 2016 Mar 7;35(38):5021–5032. doi: 10.1038/onc.2016.38

Table 1.

Testing for gender-specific prevalences of each fusion genotype in synovial sarcomagenesis.

Study SS18-SSX1 SS18-SSX2
Male Female Male Female
Ladanyi, et al., 2002 73 72 31 56
Guillou, et al., 2004 61 51 19 34
Amary, et al., 2007 34 35 20 21
Sun, et al., 2009 32 18 47 44
Takenaka, et al., 2008 31 37 13 27
Ren, et al., 2013 27 20 29 12
Messelani, et al. 2001 21 19 7 17
Nakayama, et al., 2010 11 12 3 8
Fernebro, et al., 2006 8 4 5 4
Koković, et al., 2004 7 10 15 15
Inagaki, et al., 2000 6 4 2 7
Tvrdík, et al., 2005 4 1 0 2
Total 315 283 191 247
2×2 contingency: SS18-SSX1 SS18-SSX2 total
Male 315 191 506
Female 283 247 530
total 598 438 1036
Ratio 1.44
Fisher exact test p = 0.0046